David C. Hanley
About David C. Hanley
David Hanley Nuvation Bio Chief Technical Operations Officer
David Hanley joined Nuvation Bio in 2021, bringing with him over 20 years of experience in the pharmaceutical industry. As the Chief Technical Operations Officer, he oversees the strategic and operational aspects of the company’s technical and operational departments. His role involves steering the company's technical vision and ensuring operational excellence in line with Nuvation Bio's mission and goals.
David Hanley Education and Expertise
David Hanley holds a Ph.D. in Physical and Analytical Chemistry from the University of Utah. Additionally, he earned a B.S. in Chemistry from Virginia Commonwealth University. His deep understanding of chemistry and analytical techniques provides a strong foundation for his extensive career in pharmaceutical development and operations.
David Hanley Background in Pharmaceutical Industry
David Hanley has accumulated substantial experience in the pharmaceutical industry, previously serving in key leadership roles at various organizations. Notably, he was the Senior Vice President and Head of Global Pharmaceutical Development and Operations at BioXcel Therapeutics, where he led the strategy and execution for CMC development, end-to-end supply chain, and external supply manufacturing.
David Hanley Achievements at Radius Health
While at Radius Health, Inc., David Hanley held significant roles, including Vice President of Pharmaceutical Sciences and Technical Operations. He led efforts in CMC development, U.S. FDA New Drug Application (NDA) processes, and the launch of FDA-approved products, demonstrating his expertise in overseeing comprehensive pharmaceutical development and supply chain management.
David Hanley's Career Path and Early Roles
David Hanley began his career with project management and scientific positions at Medarex and Berlex, a subsidiary of Schering AG. These early roles laid the groundwork for his later accomplishments, including senior directorship at The Medicines Company and other influential roles within the industry. His growth through various leadership positions highlights his extensive experience and adaptability in pharmaceutical development and operations.